LEAP-TREG
Dead / Abandoned — Abandoned — failure to respond (as of 08 Feb 2025)
What this means for you
This application is over — abandoned 21 Jan 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97923209
- Mark type
- Stylized text
- Filed
- 05 May 2023
- Abandoned
- 21 Jan 2025
- Attorney of record
- Andrew D. Bochner
Goods and services
- Class 040 — Treatment of materials: Custom manufacturing of biopharmaceutical preparations for cell and gene therapy and stem cell therapy
- Class 042 — Scientific and technological services: Testing, research, and development of biopharmaceutical preparations for cell and gene therapy and stem cell therapy; Scientific services, namely, testing, scientific research and development in the field of processes for cell and gene therapy and stem cell therapy; stem cell research services and clinical research in the field of gene therapy; consulting services in the fields of biopharmaceutical research and development and genetic science
Owner
- BioCentriq, Inc., Newark, NJ, US
Prosecution history
- 08 Feb 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 08 Feb 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 18 Oct 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 18 Oct 2024 — FINAL REFUSAL E-MAILED
- 18 Oct 2024 — FINAL REFUSAL WRITTEN
- 16 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Aug 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 May 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 15 May 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 15 Feb 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Feb 2024 — NON-FINAL ACTION E-MAILED
- 15 Feb 2024 — NON-FINAL ACTION WRITTEN
- 31 Jan 2024 — ASSIGNED TO EXAMINER
- 24 Jul 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED